Evofem Biosciences, Inc. (EVFM) |
| 0.009 -0 (-1.1%) 01-13 15:58 |
| Open: | 0.0094 |
| High: | 0.0094 |
| Low: | 0.009 |
| Volume: | 7,680 |
| Market Cap: | 1(M) |
| PE Ratio: | -0.18 |
| Exchange: | Other OTC |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.04 |
| Resistance 1: | 0.03 |
| Pivot price: | 0.02 |
| Support 1: | 0.01 |
| Support 2: | 0.01 |
| 52w High: | 0.02 |
| 52w Low: | 0.006 |
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Financials
| EPS | -1.400 |
| Book Value | -0.760 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.058 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 21 Nov 2025
Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE - PR Newswire
Thu, 13 Nov 2025
Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update - PR Newswire
Mon, 20 Oct 2025
Evofem shareholders reject merger with Aditxt, company pivots to seek listing - Investing.com
Mon, 20 Oct 2025
Evofem Announces Voting Results from Special Meeting of Stockholders - Financial Times
Fri, 26 Sep 2025
Evofem Biosciences Honors World Contraception Day - PR Newswire
Thu, 11 Sep 2025
Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms - PR Newswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
